These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38112449)

  • 41. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
    Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
    Front Immunol; 2021; 12():668391. PubMed ID: 34539622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
    Qiu H; Tian W; He Y; Li J; He C; Li Y; Liu N; Li J
    Front Oncol; 2021; 11():654350. PubMed ID: 33954112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade glioma.
    Yang J; Shen L; Yang J; Qu Y; Gong C; Zhou F; Liu Y; Luo M; Zhao L
    Transl Cancer Res; 2024 Jan; 13(1):112-136. PubMed ID: 38410234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Focusing on scRNA-seq-Derived T Cell-Associated Genes to Identify Prognostic Signature and Immune Microenvironment Status in Low-Grade Glioma.
    Wen J; Huang Q; Yao J; Wei W; Li Z; Zhang H; Chang S; Pei H; Cao Y; Li H
    Mediators Inflamm; 2023; 2023():3648946. PubMed ID: 37292257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cuprotosis clusters predict prognosis and immunotherapy response in low-grade glioma.
    Zhu W; Chen Z; Fu M; Li Q; Chen X; Li X; Luo N; Tang W; Yang F; Zhang Y; Zhang Y; Peng X; Hu G
    Apoptosis; 2024 Feb; 29(1-2):169-190. PubMed ID: 37713112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas.
    Wang C; He Z
    Front Pharmacol; 2023; 14():1276466. PubMed ID: 38053842
    [No Abstract]   [Full Text] [Related]  

  • 47. Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma.
    Yan X; Ji H; Liu Z; Ma S; Dong J; Jiang X; Hu X; Wang F; Zhao H; Jin J; Zhang J; Wang N; Du J; Hu S
    Front Genet; 2022; 13():880864. PubMed ID: 35559020
    [No Abstract]   [Full Text] [Related]  

  • 48. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 49. Identification of Critical m
    Zheng J; Wang X; Qiu Y; Wang M; Yu H; Zhou Z; Wu Z; Jiang X
    Biomed Res Int; 2021; 2021():9959212. PubMed ID: 34212046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Potential of Secreted Modular Calcium-Binding Protein 1 in Low-Grade Glioma.
    Wang J; Xia S; Zhao J; Gong C; Xi Q; Sun W
    Front Mol Biosci; 2021; 8():666623. PubMed ID: 34869577
    [No Abstract]   [Full Text] [Related]  

  • 53. The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma.
    Hu Y; Yang Q; Cai S; Wang W; Fu S
    Front Genet; 2023; 14():1085584. PubMed ID: 37091789
    [No Abstract]   [Full Text] [Related]  

  • 54. Expression and clinical significance of RBBP4 gene in lower-grade glioma: An integrative analysis.
    Liang R; Xiang Y; Hu C; Tang X
    Biochem Biophys Rep; 2023 Sep; 35():101533. PubMed ID: 37664524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
    Chen Y; Li Q; Zhang J; Gu R; Li K; Zhao G; Yuan H; Feng T; Ou D; Lin P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Jun; 37(3):469-479. PubMed ID: 32597089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification.
    Zhou Y; Xiao D; Jiang X
    J Transl Med; 2022 Jul; 20(1):335. PubMed ID: 35879775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel peroxisome-related gene signature predicts clinical prognosis and is associated with immune microenvironment in low-grade glioma.
    Gao D; Zhou Q; Hou D; Zhang X; Ge Y; Zhu Q; Yin J; Qi X; Liu Y; Lou M; Zhou L; Bi Y
    PeerJ; 2024; 12():e16874. PubMed ID: 38406287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and validation of RNA methylation-related alternative splicing gene signature for low-grade glioma to predict survival and immune landscapes.
    Ma C; Bao Y; Xu J; Xiao B; Li H
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):47-62. PubMed ID: 36528831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and validation of a risk model and molecular subtypes based on tryptophan metabolism-related genes to predict the clinical prognosis and tumor immune microenvironment in lower-grade glioma.
    Li W; Ling L; Xiang L; Ding P; Yue W
    Front Cell Neurosci; 2023; 17():1146686. PubMed ID: 36925967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.